MedPage Today on MSN
CAR7 Gene Therapy Shows Promise in T-Cell ALL
The use of base editing to generate universal off-the-shelf CAR T cells induced durable remissions -- up to 36 months in one ...
Patients treated in an outpatient setting who later required admission spent an average of 12.1 days in the hospital, ...
Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency ...
A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding ...
The analyzer consists of a main unit and embedded analysis software. The main unit integrates an optical imaging system, sample-handling module, barcode scanner, automatic oil-immersion unit, control ...
Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on ...
A newly identified and rare genetic variant slows the growth of mutated blood stem cells and reduces the risk of leukemia.
In this MedPage Today video, Taylor Brooks, MD, of the Cleveland Clinic Cancer Institute, discusses real-world survival ...
News-Medical.Net on MSN
IV iron dextran more cost-effective than oral iron for women with heavy menstrual bleeding and IDA
A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and ...
The Class II medical device, an AI-Automated Human Blood Cell Morphology Analyzer, received approval from the Hunan ...
Shares of WORK Medical are rising Monday after the company received manufacturing approval for one of its AI-powered products ...
Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results